Arterial stiffness and endothelial dysfunction in HIV-infected children

被引:112
作者
Bonnet, D
Aggoun, Y
Szezepanski, I
Bellal, N
Blanche, S
机构
[1] Hop Necker Enfants Malad, Serv Cardiol Pediat, APHP, Dept Pediat, F-75743 Paris 15, France
[2] Fac Med Necker Enfants Malad, INSERM, EMI 0016, Paris, France
关键词
endothelium; paediatrics; antiretroviral therapy; protease inhibitors;
D O I
10.1097/00002030-200404300-00012
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: The role of antiretroviral therapy in acceleration of atherosclerosis in HIV-infected adults is controversial, partly because of the confounding effects of the involvement of classic cardiovascular risk factors. Objective: To study vascular function in HIV-infected children. Design: Cross-sectional study of 49 HIV-infected children (34 receiving antiretroviral therapy and 15 never treated) and if 24 age- and sex-matched controls. Methods: Automatic, computerized, ultrasonic procedure evaluation of geometric and mechanical properties of the common carotid artery, and of the endothelium-dependent dilation and endothelium-independent dilation. Results: Relative systolodiastolic variations in diameter of the carotid artery in HIV-infected children were significantly lower than those in controls, but there was no significant difference in intima-media thickness. Cross-sectional compliance and distensibility were also significantly lower. Wall stiffness, assessed as the incremental elastic modulus, was larger in HIV-infected children. Endothelium-dependent dilation was lower in HIV-infected children but non-endothelium-dependent dilation was similar to that in controls. We did not find differences for any of the vascular variables between HIV-infected children receiving antiretroviral therapy and those never treated. All arterial variables were similar in children with and without dyslipidemia. Conclusions: HIV-infected children had a vascular dysfunction in the absence of cardiovascular risk factors. In this short series, no additional detrimental effects were observed after a mean of 5 years of antiretroviral therapy. (C) 2004 Lippincott Williams Wilkins.
引用
收藏
页码:1037 / 1041
页数:5
相关论文
共 21 条
[11]   Metabolic abnormalities in HIV type 1-infected children treated and not treated with protease inhibitors [J].
Melvin, AJ ;
Lennon, S ;
Mohan, KM ;
Purnell, JQ .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2001, 17 (12) :1117-1123
[12]   Evaluation of cardiovascular risk factors in HIV-1 infected patients using carotid intima-media thickness measurement [J].
Mercié, P ;
Thiébaut, R ;
Lavignolle, V ;
Pellegrin, JL ;
Yvorra-Vives, MC ;
Morlat, P ;
Ragnaud, JM ;
Dupon, M ;
Malvy, D ;
Bellet, H ;
Lawson-Ayayi, S ;
Roudaut, R ;
Dabis, F .
ANNALS OF MEDICINE, 2002, 34 (01) :55-63
[13]  
Park S H, 1996, J Am Soc Echocardiogr, V9, P119, DOI 10.1016/S0894-7317(96)90019-X
[14]   CORONARY-ARTERY LESIONS AND HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION [J].
PATON, P ;
TABIB, A ;
LOIRE, R ;
TETE, R .
RESEARCH IN VIROLOGY, 1993, 144 (03) :225-231
[15]   HIV envelope gp120 activates human arterial smooth muscle cells [J].
Schecter, AD ;
Berman, AB ;
Yi, L ;
Mosoian, A ;
McManus, CM ;
Berman, JW ;
Klotman, ME ;
Taubman, MB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (18) :10142-10147
[16]   Assessment of atherosclerosis using carotid ultrasonography in a cohort of HIV-positive patients treated with protease [J].
Seminari, E ;
Pan, A ;
Voltini, G ;
Carnevale, G ;
Maserati, R ;
Minoli, L ;
Meneghetti, G ;
Tinelli, C ;
Testa, S .
ATHEROSCLEROSIS, 2002, 162 (02) :433-438
[17]  
Sharland M, 2002, HIV Med, V3, P215, DOI 10.1046/j.1468-1293.2002.00120.x
[18]   Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction [J].
Stein, JH ;
Klein, MA ;
Bellehumeur, JL ;
McBride, PE ;
Wiebe, DA ;
Otvos, JD ;
Sosman, JM .
CIRCULATION, 2001, 104 (03) :257-262
[19]   Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: a prospective study [J].
Tounian, P ;
Aggoun, Y ;
Dubern, B ;
Varille, V ;
Guy-Grand, B ;
Sidi, D ;
Girardet, JP ;
Bonnet, D .
LANCET, 2001, 358 (9291) :1400-1404
[20]   Efficacy of highly active antiretroviral therapy in HIV-1 infected children [J].
van Rossum, AMC ;
Fraaij, PLA ;
de Groot, R .
LANCET INFECTIOUS DISEASES, 2002, 2 (02) :93-102